Medicilon is the leading Preclinical Contract Research Organization (CRO), providing bioanalytical cro services to the global biopharmaceutical markets.
Our protein analytical services could identify a protein by molecular weight, sequence confirm the primary structure of a protein and detect post translational modifications, characterize a protein by aggregation, thermostability, size, charge, and pI, measure a protein’s purity/impurity, determine the amino acid sequences of a purified protein sample or discover the amino acid sequence of an antibody, compare one protein or antibody sample to a second sample or biosimilar molecule, and more.
Bioanalytical Services for Preclinical Studies:
- Bioanalytical Method Development and Validation
- Dose Formulation Analysis
- Bioanalysis of Preclinical and Clinical Samples
- Test Articles: Small Molecules and Large Molecules, including Protein, DNA, RNA, Vaccines
- Biomarker Analysis
Small Molecule Bioanalytical Services:
- International Clinical Trials
- BA/BE Studies
- GLP-Compliant Preclinical Research
- Early DMPK Screening
- Reference Standards and Stable Isotope Labeled Internal Standards Synthesis
Large Molecule Bioanalytical Services:
Medicilon offers comprehensive and FDA/CFDA GLP-compliant bioanalysis services to support preclinical and clinical development for small molecule drugs, biologics, vaccines and biomarkers.
We leverage the experience of our leaders, managers and scientists to effectively meet clients’ requirements of accurate, timely, high-quality results with:
- Efficient, timely support of complex analytical challenges
- Advice on procedures/methods to obtain the needed data
- Refined analytical standard operating procedures (SOPs) and lab procedures
